Search
for
Sort by
Research 301–330 of 775
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Surgical Approaches for Repigmenting Vitiligo 2.0
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis